mTOR inhibits autophagogenesis.[74,75] According to Wang et al,[76] mTOR may prevent CS-induced inflammation and emphysema by reducing autophagy and apoptosis, indicating that mTOR activation may be a therapeutic target for COPD. The gene discussed is MTOR; the disease is pulmonary emphysema.